Michael J. Cork, A. Wollenberg, E.C. Siegfried, A.B. Rossi, Z. Chen, N.A. Levit, A. Rodriguez Marco,
... 6–11 years with severe AD. In the LIBERTY AD PEDS study (NCT03345914), children were randomized 1: ...
Tópico(s): Allergic Rhinitis and Sensitization
2023 - Elsevier BV | Revue française d'allergologie
A.S. Paller, A. Wollenberg, E.C. Siegfried, M.E. Gonzalez, B.L. Lockshin, Ana B. Rossi, Fouad A. Khokhar, Z. Chen, T. Gonzalez, Randy Prescilla,
... moderate-to-severe AD treated with dupilumab (DPL). LIBERTY AD INFANT/PRE-SCHOOL (NCT03346434 part B), a ...
Tópico(s): Food Allergy and Anaphylaxis Research
2023 - Elsevier BV | Revue française d'allergologie